Physiologic changes in homocysteine metabolism in pregnancy: A longitudinal study in Spain

Nutrition

Volumn 27, Issue 9, 2011, Pages 925-930

  Úbeda, Natalia ^a   Reyes, Leticia ^a   González Medina, Antonio ^a   Alonso Aperte, Elena ^a   Varela Moreiras, Gregorio ^a  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

Author keywords

Folic acid; Homocysteine; Methylenetetrahydrofolate reductase; Pregnancy; Vitamin B12

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AMINO ACID METABOLISM; ARTICLE; BLOOD EXAMINATION; FEMALE; FIRST TRIMESTER PREGNANCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INTRAUTERINE GROWTH RETARDATION; LONGITUDINAL STUDY; MATERNAL HYPERTENSION; NUTRITIONAL STATUS; POLYMERASE CHAIN REACTION; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SECOND TRIMESTER PREGNANCY; SPAIN; THIRD TRIMESTER PREGNANCY; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

ADULT; DIABETES, GESTATIONAL; DIETARY SUPPLEMENTS; FEMALE; FETAL GROWTH RETARDATION; FOLIC ACID; GENOTYPE; HOMOCYSTEINE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; LONGITUDINAL STUDIES; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NUTRITION POLICY; POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY COMPLICATIONS; PREVALENCE; SPAIN; VITAMIN B 12;

EID: 79960942630     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2010.10.017     Document Type: Article

References (64)

1. Hibbard B.M. The role of folic acid in pregnancy with particular reference to anaemia, abruption and abortion. J Obstet Gynaecol Br Commonw 1964, 71:529-542.
2. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991, 338:131-137. MRC Vitamin Study Research Group.
3. Czeizel A.E., Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992, 327:1832-1835.
4. Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Final rule. Fed Regist 1996, 61:8781-8797.
5. Selhub J. Homocysteine metabolism. Annu Rev Nutr 1999, 19:217-246.
6. Vollset S.E., Refsum H., Ueland P.M. Populations determinants of homocysteine. Am J Clin Nutr 2001, 73:499-500.
7. Hague W.M. Homocysteine and pregnancy. Best Pract Res Clin Obstet Gynecol 2003, 17:459-469.
8. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 1998, 316:894-898. Homocysteine Lowering Trialists' Collaboration.
9. Brattstrom L., Wilcken D.E.L., Ohrvik J., Brudin L. Common methylentetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease. The result of a meta-analysis. Circulation 1998, 98:2520-2526.
10. Anderson A., Hultberg B., Brattström L., Isaksson A. Decreased serum homocysteine in pregnancy. Eur J Clin Chem Clin Biochem 1992, 30:377-379.
11. Walker M.C., Smith G.N., Perkins S.L., Keely E.J., Garner P.R. Changes in homocysteine levels during normal pregnancy. Am J Obstet Gynecol 1999, 180:660-664.
12. Cikot R.J.L.M., Steegers-Theunissen R.P.M., Thomas C.M.G., de Boo T.M., Merkus H.M.W.M., Steegers E.A.P. Longitudinal vitamin and homocysteine levels in normal pregnancy. Br J Nutr 2001, 85:49-58.
13. Murphy M.M., Scott J.M., McPartlin J.M., Fernández-Ballart J.D. The pregnancy-related decrease in fasting plasma homocysteine is not explained by folic acid supplementation, hemodilution, or a decrease in albumin in a longitudinal study. Am J Clin Nutr 2002, 76:614-619.
14. Steegers-Theunissen R.P., Boers G.H., Trijbels F.J., Eskes T.K. Neural tube defects and derangement of homocysteine metabolism. N Engl J Med 1991, 324:199-200.
15. Mills J.L., McPartlin J.M., Kirke P.N., Lee Y.J., Conley M.R., Weir D.G., et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 1995, 345:149-151.
16. Rosenquist T.H., Ratashak S.A., Selhub J. Homocysteine induces congenital defects on the heart and neural tube defect: effect of folic acid. Proc Natl Acad Sci U S A 1995, 93:15227-15232.
17. Nelen W.L.D.M., Blom H.K., Steegers E.P.A., Den Heijer M., Thomas C.M.G., Eskes T.K.A.B. Homocysteine and folate levels as risk factors for recurrent early pregnancy loss. Obstet Gynecol 2002, 95:519-524.
18. Van der Molen E.F., Verbruggen B., Nováková I., Eskes T.K.A.B., Monnens L.A.H., Blom H.J. Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy. Br J Obstet Gynaecol 2002, 107:785-791.
19. Vollset S.E., Refsum H., Irgens L.M., Emblem B.M., Tverdal A., Gjessing H.K., et al. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. Am J Clin Nutr 2000, 71:962-968.
20. Ashfield-Watt P.A.L., Pullin C.H., Whiting J.M., Clark Z.E., Moat S.J., Newcombe R.G., et al. Methylenetetrahydrofolate reductase 677CT genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial. Am J Clin Nutr 2002, 76:180-186.
21. Kim K.N., Kim Y.J., Chang N. Effects of the interaction between the C677T 5,10-methylenetetrahydrofolate reductase polymorphism and serum B vitamins on homocysteine levels in pregnant women. Eur J Clin Nutr 2004, 58:10-16.
22. Ueland P.M., Vollset S.E. Homocysteine and folate in pregnancy. Clin Chem 2004, 50:1293-1295.
23. 12 during early embryogenesis. Food Nutr Bull 2008, 29(suppl 1):S86-S98.
24. Delgado Beltrán P., Melchor Marcos J.C., Rodríguez-Alarcón Gómez J., Linares Uribe A., Fernández-Llebrez del Rey L., Barbazán Cortés M.J., et al. Curvas de desarrollo fetal de los recién nacidos en el Hospital de Cruces (Vizcaya). An Esp Pediatr 1996, 44:50-54.
25. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2002;25(suppl 1):S94-S96.
26. Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The organizing committee. Diabetes Care 1998;21(suppl 2):B161-7.
27. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995, 10:111-113.
28. Moreiras O., Carbajal A., Cabrera L., Cuadrado C. Tablas de composición de alimentos 2008, Pirámide, Madrid. 12nd ed.
29. Murphy M.M., Scott J.M., Molloy A.M., Arija V., Fernández-Ballart J.D. Association between estradiol and homocysteine fluctuations during pregnancy. J Inherit Metab Dis 2003, 26(suppl 1):34.
30. Holmes V.A., Wallace J.M.W., Alexander H.D., Gilmore W.S., Bradbury I., Ward M., et al. Homocysteine is lower in the third trimester of pregnancy in women with enhanced folate status from continued folic acid supplementation. Clin Chem 2005, 51:629-634.
31. Vujkovic M., Steegers E.A., Looman C.W., Ocké M.C., van der Spek P.J., Steegers-Theunissen R.P. The maternal Mediterranean dietary pattern is associated with a reduced risk of spina bifida in the offspring. Int J Obstet Gynaecol 2009, 116:408-415.
32. Murphy M.M., Scott J.M., Arija V., Molloy A.M., Fernández-Ballart J.D. Maternal homocysteine before conception and throughout pregnancy predicts fetal homocysteine and birth weight. Clin Chem 2004, 50:1406-1412.
33. Murphy M.M., Molloy A.M., Ueland P.M., Fernández-Ballart J.D., Schneede J., Arija V., et al. Longitudinal study of the effect of pregnancy on maternal and fetal cobalamin status in healthy women and their offspring. J Nutr 2007, 137:1863-1867.
34. López-Quesada E., Vilaseca M.A., Lailla J.M. Plasma total homocysteine in uncomplicated pregnancy and in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2003, 108:45-49.
35. Also-Rallo E., López-Quesada E., Urreizti R., Vilaseca M.A., Lailla J.M., Balcells S., et al. Polymorphisms of genes envolved in homocysteine metabolism in preeclampsia and in uncomplicated pregnancies. Eur J Obstet Gynecol Reprod Biol 2005, 120:45-52.
36. Jacques P.F., Selhub J., Bostom A., Wilson P., Rosenberg I. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Eng J Med 1999, 340:1449-1454.
37. Choumenkovitch S.F., Jacques P.F., Nadeau M.R., Wilson P.W., Rosenberg I.H., Selhub J. Folic acid fortification increases red blood cell folate concentrations in the Framingham study. J Nutr 2001, 131:3277-3280.
38. Coll O., Pisa S., Palacio M., Quinto L., Cararch V. Awareness of the use of folic acid to prevent neural tube defects in a Mediterranean area. Eur J Obstet Reprod Biol 2005, 115:173-177.
39. Velzing-Aarts F.V., Holm P.I., Fokkema M.R., van der Dijs F.P., Ueland P.M., Muskiet F.A. Plasma choline and betaine and their relation to plasma homocysteine in normal pregnancy. Am J Clin Nutr 2005, 81:1383-1388.
40. Wallace J.M.W., Bonham M.P., Strain J.J., Duffy E.M., Robson P.J., Ward M., et al. Homocysteine concentration, related B vitamins, and betaine in pregnant women recruited to the Seychelles Child Development Study. Am J Clin Nutr 2008, 87:391-397.
41. Guerra-Shinohara E.M., Paiva A.A., Rondo P., Yamasaki K., Terzi C.A., D'Almeida V. Relationship between total homocysteine and folate levels in pregnant women and their newborn babies according to maternal serum levels of vitamin B12. BJOG 2002, 109:784-791.
42. Candito M., Magnaldo S., Bayle J., Dor J.F., Gillet Y., Bongain A., et al. Clinical B12 deficiency in one case of recurrent spontaneous pregnancy loss. Clin Chem Lab Med 2003, 41:1026-1027.
43. Gaber K.R., Farag M.K., Soliman S.E., El-Bassyouni H.T., El-Kamah G. Maternal vitamin B12 and the risk of fetal neural tube defects in Egyptian patients. Clin Lab 2007, 53:69-75.
44. Ray J.G., Wyatt P.R., Thompson M.D., Vermeulen M.J., Meier C., Wong P.Y., et al. Vitamin B12 and the risk of neural tube defects in a folic acid fortified population. Epidemiology 2007, 18:362-366.
45. Hübner U., Alwan A., Jouma M., Tabbaa M., Schorr H., Herrmann W. Low serum vitamin B12 is associated with recurrent pregnancy loss in Syrian women. Clin Chem Lab Med 2008, 46:1265-1269.
46. Yajnik C.S., Deshpande S.S., Jackson A.A., Refsum H., Rao S., Fisher D.J., et al. Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study. Diabetologia 2008, 51:29-38.
47. 12 deficiency, higher serum folate is associated with increased total homocysteine and methylmalonic acid concentrations. PNAS 2007, 104:19995-20000.
48. González González M.P., Moreno Almazán L., Cornide M., García Rico E., Alonso-Aperte E., Varela Moreiras G. Homocisteína, folatos y vitamina B12 y cáncer colorrectal. Estudio caso control en humanos. Nutr Hosp 2005, 20:28-29.
49. Varela-Moreiras G., Escudero J.M. Alonso-Aperte. Homocisteína, vitaminas relacionadas y estilos de vida en personas de edad avanzada: estudio Séneca. Nutr Hosp 2007, 22:363-370.
50. Partearroyo Cediel T. Deficiencia y suplementación dietaria con ácido fólico durante el crecimiento y el enevejecimiento en rata: estudio nutricional y bioquímico. Diploma de estudios avanzados 2006, Universidad San Pablo CEU, Madrid.
51. Martínez-Frías M.L., Bermejo E., Rodríguez-Pinilla E., Scala I., Andria G., Botto L. Frequency of the mutation 677C-T of methylenetetrahydrofolate reductase gene on a sample of 652 Spanish liveborn infants. Med Clin (Barc) 2004, 122:361-364.
52. Guillén M., Corella D., Portolés O., González J.I., Mulet F., Saiz C. Prevalence of the methylenetetrahydrofolate reductase 677C>T mutation in the Mediterranean Spanish population. Association with cardiovascular risk factors. Eur J Epidemiol 2001, 17:255-261.
53. Gutiérrez Revilla J.I., Pérez Hernández F., Calvo Martín M.T., Tamparillas Salvador M., Gracia Romero J. Implicación de los polimorfismos C677T y A1298C del gen MTHFR en el desarrollo de los defectos del tubo neural en la población española. Med Clin (Barc) 2003, 120:441-445.
54. González-Pérez E., Via M., López-Alomar A., Esteban E., Valveny N., Bao M., et al. Lack of association between methylenetetrahydrofolate reductase (MTHFR) C677T and ischaemic heart disease (IHD): family-based association study in a Spanish population. Clin Genet 2002, 62:235-239.
55. González Medina A. Mutación C677T en el gen de la metiléntetrahidrofolato reductasa. Prevalencia y relación con complicaciones de la gestación. Diploma de estudios avanzados 2001, Universidad San Pablo CEU, Madrid.
56. Powers R.W., Dunbar M.S., Gallaher M.J., Roberts J.M. The 677 C-T methylenetetrahydrofolate reductase mutation does not predict increased maternal homocysteine during pregnancy. Obstet Gynecol 2003, 101:762-766.
57. Dodds l, Feli D.B., Dooley K.C., Armson B.A., Allen A.C., Nassar B.A., et al. Effect of homocysteine concentration in early pregnancy on gestational hypertensive disorders and other pregnancy outcomes. Clin Chem 2008, 54:326-334.
58. Hogg B.B., Tamura T., Johnston K.E., DuBard M.B., Goldenberg R.L. Second-trimester plasma homocysteine levels and pregnancy-induced hypertension, preeclampsia, and intrauterine growth restriction. Am J Obstet Gynecol 2000, 183:805-809.
59. Ronnenberg A.G., Goldman M.B., Chen D., Aitken I.W., Willett W.C., Selhub J., et al. Preconception homocysteine and B vitamin status and birth outcomes in Chineses women. Am J Clin Nutr 2002, 76:1385-1391.
60. Infante-Rivard C., Rivard G.E., Gauthier R., Théorêt Y. Unexpected relationship between plasma homocysteine and intrauterine growth restriction. Clin Chem 2003, 49:1476-1482.
61. Onalan R., Onalan G., Gunec Z., Karabulut E. Combining 2nd-trimester maternal serum homocysteine concentrations and uterine artery Doppler for prediction of preeclampsia and isolated intrauterine growth restriction. Gynecol Obstet Invest 2006, 61:142-148.
62. Goldenberg R.L., Tamura R., Cliver S.P., Cutter G.R., Hoffman H.J., Copper R.L. Serum folate and fetal growth retardation: a matter of compliance?. Obstet Gynecol 1992, 79:719-722.
63. Pagán K., Hou J., Goldenberg R.L., Cliver S.P., Tamura T. Effect of smoking on serum concentrations of total homocysteine and B vitamins in mid-pregnancy. Clin Chim Acta 2001, 306:103-109.
64. Andres R.L., Day M.C. Perinatal complications associated with maternal tobacco use. Semin Neonatol 2000, 5:231-241.